| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-11 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.31 | 6e-07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |